Other languages Assertio Holdings, Inc.

Equities

ASRT

US04546C2052

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
0.8282 ^USD	+5.49%		+7.14%	-22.60%

02/04	James L. Tyree, Chairman of the Compensation Committee of the Board of Directors of Assertio Holdings, Inc. Declines to Stand for Reelection	CI
12/03	Lake Street Adjusts Assertio Therapeutics' Price Target to $3 From $4, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

James L. Tyree, Chairman of the Compensation Committee of the Board of Directors of Assertio Holdings, Inc. Declines to Stand for Reelection	03/04
Assertio Holdings, Inc. Appoints Sigurd Kirk to the Board, Effective April 3, 2024	12/03
Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024	12/03
Assertio Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	12/03
Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors	27/01
Assertio Holdings, Inc. Announces Executive Changes	06/01
Assertio Holdings CEO Steps Down, Names Interim CEO	03/01
Assertio Holdings, Inc. Announces CEO Changes	03/01
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors	14/11
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech	09/11
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	09/11
Top Premarket Decliners	09/11
Assertio Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Assertio Holdings, Inc. Announces Executive Changes	09/11
Top Midday Decliners	04/23/04
Assertio Therapeutics Completes Acquisition of Spectrum Pharmaceuticals, Reports Lower Q2 Adjusted Earnings	04/23/04
Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023	04/23/04
Assertio Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/23/04
Assertio Holdings Closes Acquisition of Spectrum Pharmaceuticals	01/23/01
Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors	01/23/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Assertio Holdings, Inc.

Equities

ASRT

US04546C2052

Other languages

Filters